Login or Sign Up
Concord Biotech Ltd. News And Announcements
12:19 Oct 31
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd.
Industry Biotechnology
12:19 Oct 31
Quality
64/100
High Financial Strength
Valuation
29/100
Expensive Valuation
Technical
34/100
Technically Bearish
Strength
7
Weakness
8
Opportunity
0
Threats
1
15.19K
Market Cap (Cr)
42.66
PE Ratio
8.39
Price to Book Ratio
34.73
RSI
30.96 %
Net Profit Margin
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully